pentoxifylline has been researched along with Leishmania Infection in 3 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pentoxifylline is a methylxanthine that inhibits phosphodiesterase IV, which inhibits the degradation of the cAMP and prostanoids." | 5.35 | Pentoxifylline down modulate in vitro T cell responses and attenuate pathology in Leishmania and HTLV-I infections. ( Carvalho, EM; Luna, T; Machado, PR; Pacheco de Almeida, R; Ribeiro de Jesus, A, 2008) |
| "Pentoxifylline is a methylxanthine that inhibits phosphodiesterase IV, which inhibits the degradation of the cAMP and prostanoids." | 1.35 | Pentoxifylline down modulate in vitro T cell responses and attenuate pathology in Leishmania and HTLV-I infections. ( Carvalho, EM; Luna, T; Machado, PR; Pacheco de Almeida, R; Ribeiro de Jesus, A, 2008) |
| "Pentoxifylline (PTX) has been shown to inhibit cytokine synthesis, including TNF-alpha." | 1.35 | Pentoxifylline prevents the meglumine antimonate-induced renal toxicity in rats, but not that induced by the inorganic antimony pentachloride. ( de Moura, FJ; de Souza Furtado, R; Leal, PP; Muniz-Junqueira, MI; Veiga, JP, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ribeiro de Jesus, A | 1 |
| Luna, T | 1 |
| Pacheco de Almeida, R | 1 |
| Machado, PR | 1 |
| Carvalho, EM | 1 |
| Ojha, RP | 1 |
| Cervantes, D | 1 |
| Fischbach, LA | 1 |
| de Moura, FJ | 1 |
| Leal, PP | 1 |
| de Souza Furtado, R | 1 |
| Muniz-Junqueira, MI | 1 |
| Veiga, JP | 1 |
3 other studies available for pentoxifylline and Leishmania Infection
| Article | Year |
|---|---|
Pentoxifylline down modulate in vitro T cell responses and attenuate pathology in Leishmania and HTLV-I infections.
Topics: Animals; HTLV-I Infections; Humans; Interferon-gamma; Leishmania; Leishmaniasis; Pentoxifylline; T-L | 2008 |
Oral pentoxifylline and pentavalent antimony for treatment of leishmaniasis: promising but inconclusive evidence of superiority, compared with antimony monotherapy.
Topics: Administration, Oral; Antimony; Drug Therapy, Combination; Humans; Leishmaniasis; Pentoxifylline | 2007 |
Pentoxifylline prevents the meglumine antimonate-induced renal toxicity in rats, but not that induced by the inorganic antimony pentachloride.
Topics: Animals; Antimony; Antiprotozoal Agents; Chlorides; Dose-Response Relationship, Drug; Kidney Disease | 2008 |